KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $0.62.

  • Pfizer's EPS (Basic) fell 2151.9% to $0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.44, marking a year-over-year increase of 22105.26%. This contributed to the annual value of $0.0 for FY2024, which is 9948.89% down from last year.
  • As of Q3 2025, Pfizer's EPS (Basic) stood at $0.62, which was down 2151.9% from $0.51 recorded in Q2 2025.
  • Pfizer's 5-year EPS (Basic) high stood at $1.77 for Q3 2022, and its period low was -$0.59 during Q4 2023.
  • Its 5-year average for EPS (Basic) is $0.54, with a median of $0.54 in 2024.
  • As far as peak fluctuations go, Pfizer's EPS (Basic) crashed by 12727.27% in 2023, and later soared by 30977000.0% in 2024.
  • Quarter analysis of 5 years shows Pfizer's EPS (Basic) stood at -$0.0 in 2021, then surged by 66545.08% to $1.54 in 2022, then tumbled by 138.31% to -$0.59 in 2023, then skyrocketed by 233.9% to $0.79 in 2024, then decreased by 21.52% to $0.62 in 2025.
  • Its EPS (Basic) stands at $0.62 for Q3 2025, versus $0.51 for Q2 2025 and $0.52 for Q1 2025.